Biovate Pharma - CT Fairfield, Westport 06880

Biovate Pharma entered the industry of Commercial Biotechnical Research in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Kevin Weber by calling (203) 642-3753 during business hours. You can also write to the business’ Single Location at 67 Maple Avenue North, Westport, Connecticut CT 06880. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Biovate Pharma
Representative: Kevin Weber
Place of Business: 67 Maple Avenue North, Westport, CT 06880
Contact Number: (203) 642-3753
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2007
Income/Year: $0 to $49.999
Laborers: 1 to 4
Share This Company:

Biovate Pharma is a company operating from Fairfield, Connecticut providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2007 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Biovate Pharma has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative Kevin Weber at (203) 642-3753 for related queries, or to locate its Single Location using the coordinates 41.148289,-73.313461.

The Single Location can also be found at the street address 67 Maple Avenue North in Westport, Connecticut 06880 and can be engaged online through the company website at , the company Twitter , and Facebook page .